ROCKVILLE, MD, USA I March 19, 2025 I REGENXBIO Inc. (Nasdaq: RGNX) today reported new, positive interim data from two additional patients in the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback